SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 202.50-2.7%Nov 7 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Alper H.YUKSEL who wrote (20931)5/16/1998 2:32:00 PM
From: John O'Neill  Read Replies (1) of 32384
 

LGND release this on May 15..has it already changed to end of quarter? after 1 day?

During the first quarter of 1998, Ligand made important progress in all of its leading drug candidates. Ligand reported positive final results of pivotal international Phase III trials for Panretin(TM) Gel and plans to file a New Drug Application (NDA) by the end of May are on schedule. Panretin(TM) Capsules also demonstrated positive results in two Phase II trials for Kaposi's sarcoma.

JO
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext